Next Generation Bio banking

Biorepositories provide a resource for researchers to increase understanding of complex diseases. Studies such as the Lung Genomics Research Consortium (LGRC), a two-year project launched in October 2009, are going a step further than standard bio banking practices and characterizing the samples with their molecular makeup. The molecular data can then be mined along with the clinical data. Led by National Jewish Health and funded by the National Heart, Lung and Blood Institute, a division of the National Institutes of Health (NIH), the LGRC project consists of five institutions, including Dana-Farber Cancer Institute. Collaborators in the project work with samples banked at the Lung Tissue Research Consortium (LTRC), which houses tissue samples and blood from lung disease sufferers, primarily chronic obstructive pulmonary disease (COPD), along with a rich set of clinical data from patients.

  • Ownership, Property Rights and Commercialization in Relation to Biobanking
  • Ethical considerations surrounding biobanking and biorepository operation.
  • Legal and Ethical Framework For Collaborative Biobanking Across Europe
  • Factors Influencing Biobanks Prices
  • Ethical issues & future use of samples

Related Conference of Next Generation Bio banking

October 14-15, 2024

17th World Congress on Stem Cell Research

Paris, France
November 21-22, 2024

11th World Congress on Epigenetics and Chromosome

Dubai, UAE

Next Generation Bio banking Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in